Your browser is no longer supported. Please, upgrade your browser.
Settings
ZSAN [NASD]
Zosano Pharma Corporation
Index- P/E- EPS (ttm)-0.33 Insider Own0.60% Shs Outstand108.94M Perf Week-0.94%
Market Cap72.91M Forward P/E- EPS next Y-0.27 Insider Trans-2.54% Shs Float- Perf Month-14.66%
Income-31.10M PEG- EPS next Q-0.08 Inst Own14.50% Short Float- Perf Quarter-19.61%
Sales0.70M P/S104.16 EPS this Y78.60% Inst Trans- Short Ratio4.87 Perf Half Y-19.10%
Book/sh0.40 P/B1.56 EPS next Y10.30% ROA-44.50% Target Price- Perf Year-7.01%
Cash/sh0.19 P/C3.30 EPS next 5Y- ROE-65.80% 52W Range0.33 - 3.06 Perf YTD18.19%
Dividend- P/FCF- EPS past 5Y60.30% ROI-56.20% 52W High-79.64% Beta3.43
Dividend %- Quick Ratio2.10 Sales past 5Y-6.50% Gross Margin20.10% 52W Low90.23% ATR0.03
Employees45 Current Ratio2.10 Sales Q/Q- Oper. Margin- RSI (14)37.29 Volatility3.03% 5.03%
OptionableNo Debt/Eq0.16 EPS Q/Q60.80% Profit Margin- Rel Volume0.65 Prev Close0.63
ShortableYes LT Debt/Eq0.05 Earnings- Payout- Avg Volume991.95K Price0.62
Recom1.70 SMA20-8.23% SMA50-9.80% SMA200-33.05% Volume647,606 Change-1.77%
Apr-17-19Initiated Maxim Group Buy $8
Mar-24-17Initiated Piper Jaffray Overweight $4
Aug-11-16Downgrade Ladenburg Thalmann Buy → Neutral
Nov-11-15Reiterated ROTH Capital Buy $11 → $7
Sep-29-15Reiterated ROTH Capital Buy $20 → $11
Feb-23-15Initiated ROTH Capital Buy $20
Oct-04-21 08:00AM  
Sep-02-21 04:30PM  
07:06AM  
Aug-10-21 06:25PM  
04:05PM  
Jul-20-21 08:30AM  
Jul-14-21 09:11AM  
Jun-11-21 09:35AM  
May-27-21 08:23AM  
May-26-21 04:05PM  
May-25-21 04:05PM  
May-12-21 04:05PM  
Apr-26-21 08:00AM  
Apr-16-21 01:52PM  
Mar-26-21 12:34PM  
Mar-11-21 04:05PM  
Mar-09-21 08:00PM  
Mar-02-21 08:30AM  
Feb-22-21 08:30AM  
Feb-01-21 08:30AM  
08:00AM  
Jan-12-21 09:08AM  
Jan-04-21 04:05PM  
08:30AM  
Dec-28-20 12:55PM  
11:59AM  
10:15AM  
10:00AM  
09:28AM  
Dec-27-20 01:00PM  
11:00AM  
Dec-26-20 03:09PM  
10:16AM  
09:35AM  
09:15AM  
Dec-25-20 09:00PM  
Dec-24-20 09:07PM  
05:18PM  
06:20AM  
Dec-23-20 10:15PM  
04:32PM  
03:00PM  
02:45PM  
02:08PM  
12:00PM  
11:00AM  
Dec-22-20 02:15PM  
12:45PM  
12:00PM  
11:30AM  
10:00AM  
09:00AM  
06:20AM  
Dec-21-20 09:00PM  
02:30PM  
01:42PM  
12:30PM  
11:30AM  
11:00AM  
06:14AM  
Dec-20-20 11:00AM  
Dec-19-20 05:19PM  
08:30AM  
Dec-18-20 07:01PM  
05:31PM  
12:30PM  
12:15PM  
11:58AM  
09:05AM  
08:00AM  
Dec-17-20 06:51PM  
05:19PM  
02:02PM  
12:35PM  
12:15PM  
11:30AM  
06:30AM  
Dec-16-20 11:30PM  
06:30PM  
05:00PM  
03:42PM  
02:15PM  
01:00PM  
12:30PM  
Dec-15-20 04:50PM  
04:04PM  
02:27PM  
12:55PM  
12:24PM  
Dec-14-20 09:55PM  
09:06PM  
01:20PM  
01:00PM  
11:45AM  
11:00AM  
06:30AM  
Dec-13-20 12:04AM  
Dec-12-20 09:00AM  
Dec-11-20 03:50PM  
03:15PM  
Zosano Pharma Corporation, a clinical stage biopharmaceutical company, focuses on providing therapeutics and other bioactive molecules to patients suffering from migraine using its transdermal microneedle system. Its lead product candidate is Qtrypta (M207), a proprietary formulation of zolmitriptan used for the acute treatment of migraine. The company was founded in 2006 and is headquartered in Fremont, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lo StevenChief Executive OfficerJun 04Sale0.8113,15810,592365,592Jun 07 06:44 PM
Lewis HayleySee RemarksJun 04Sale0.811,7091,37649,779Jun 07 06:43 PM
Matthews ChristineChief Financial OfficerJun 04Sale0.811,7091,37698,291Jun 07 06:41 PM
KELLERMAN DONALD JVP, Clinical Dev & Med AffairsJun 04Sale0.811,7091,37650,337Jun 07 06:42 PM